Beyond its effect on cancer cell proliferation, we investigated its potential to modulate NF-κB signaling, a pathway critically involved in inflammation-driven tumor progression, resistance to apoptosis, and therapy failure in various cancers [28,29]. The gene discussed is NFKB1; the disease is neoplasm.